Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

octapharma benelux sa-nv - protein s 12 iu/ml - 32 iu/ml; human coagulation factor x 18 iu/ml - 30 iu/ml; human coagulation factor ix 25 iu/ml; human coagulation factor ii 14 iu/ml - 38 iu/ml; protein c 7 iu/ml - 31 iu/ml; human coagulation factor vii 9 iu/ml - 24 iu/ml - powder and solvent for solution for infusion - 500 iu - human coagulation factor ii 14.5 iu/ml; human coagulation factor ix 25 iu/ml; human coagulation factor vii 16.5 iu/ml; human coagulation factor x 24 iu/ml; protein c 19 iu/ml; protein s 19.5 iu/ml - coagulation factor ix, ii, vii and x in combination

Canada - engelsk - Health Canada

octapharma pharmazeutika produktionsges m b h - coagulation factor ii (human); coagulation factor vii (human); coagulation factor ix (human); coagulation factor x (human); protein c; protein s - kit - 760unit; 480unit; 500unit; 600unit; 620unit; 640unit - coagulation factor ii (human) 760unit; coagulation factor vii (human) 480unit; coagulation factor ix (human) 500unit; coagulation factor x (human) 600unit; protein c 620unit; protein s 640unit - hemostatics

Canada - engelsk - Health Canada

csl behring canada inc - coagulation factor ii (human); coagulation factor vii (human); coagulation factor ix (human); coagulation factor x (human); protein c; protein s - powder for solution - 800unit; 500unit; 620unit; 1020unit; 820unit; 680unit - coagulation factor ii (human) 800unit; coagulation factor vii (human) 500unit; coagulation factor ix (human) 620unit; coagulation factor x (human) 1020unit; protein c 820unit; protein s 680unit - hemostatics

Canada - engelsk - Health Canada

csl behring canada inc - coagulation factor ii (human); coagulation factor vii (human); coagulation factor ix (human); coagulation factor x (human); protein c; protein s - powder for solution - 1600unit; 1000unit; 1240unit; 2040unit; 1640unit; 1360unit - coagulation factor ii (human) 1600unit; coagulation factor vii (human) 1000unit; coagulation factor ix (human) 1240unit; coagulation factor x (human) 2040unit; protein c 1640unit; protein s 1360unit - hemostatics

Canada - engelsk - Health Canada

octapharma pharmazeutika produktionsges m b h - coagulation factor ii (human); coagulation factor vii (human); coagulation factor ix (human); coagulation factor x (human); protein c; protein s - kit - 1520unit; 960unit; 1000unit; 1200unit; 1240unit; 1280unit - coagulation factor ii (human) 1520unit; coagulation factor vii (human) 960unit; coagulation factor ix (human) 1000unit; coagulation factor x (human) 1200unit; protein c 1240unit; protein s 1280unit - hemostatics

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga marketing sdn bhd - protein s; protein c; human coagulation factor ix; human coagulation factor ii; human coagulation factor vii; human coagulation factor x -

Israel - engelsk - Ministry of Health

csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - powder and solvent for solution for injection - coagulation factor ii (human) 200 - 480 iu; coagulation factor vii (human) 100 - 250 iu; coagulation factor ix (human- rfixfc) 200 - 310 iu; coagulation factor x (human) 220 - 600 iu; protein c 150 - 450 iu; protein s antigen 120 - 380 iu - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Israel - engelsk - Ministry of Health

csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - powder and solvent for solution for injection - coagulation factor ii (human) 400 - 960 iu; coagulation factor vii (human) 200 - 500 iu; coagulation factor ix (human- rfixfc) 400 - 620 iu; coagulation factor x (human) 440 - 1200 iu; protein c 300 - 900 iu; protein s antigen 240 - 760 iu - coagulation factor ix, ii, vii and x in combination - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Malta - engelsk - Medicines Authority

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - powder and solvent for solution for infusion - protein c 13 - 31 iu/ml human coagulation factor ii 14-38 iu/ml human coagulation factor ix 25 iu/ml human coagulation factor vii 9 -24 iu/ml human coagulation factor x 18 - 30 iu/ml protein s 12 - 32 iu/ml - antihemorrhagics

Malta - engelsk - Medicines Authority

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - powder and solvent for solution for infusion - human coagulation factor ii 14 - 38 iu/ml human coagulation factor vii 9 - 24 iu/ml human coagulation factor x 18 - 30 iu/ml protein c 13 - 31 iu/ml protein s 12 - 32 iu/ml human coagulation factor ix 25 iu/ml - antihemorrhagics